Holen Sie sich die Stockscreener-App
5.875
1.18%
-0.07
Schlusskurs vom Vortag:
$5.945
Offen:
$5.95
24-Stunden-Volumen:
8,553
Relative Volume:
0.41
Marktkapitalisierung:
$24.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.56M
KGV:
-0.3493
EPS:
-16.82
Netto-Cashflow:
$-12.46M
1W Leistung:
+1.60%
1M Leistung:
-3.85%
6M Leistung:
-8.27%
1J Leistung:
+71.28%
1-Tages-Spanne:
$5.83
$6.05
1-Wochen-Bereich:
$5.7663
$6.10
52-Wochen-Spanne:
$2.80
$7.89
Tenax Therapeutics Inc Stock (TENX) Company Profile
Firmenname
Tenax Therapeutics Inc
Sektor
Branche
Telefon
919-855-2100
Adresse
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Vergleichen Sie TENX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
5.86 | 23.90M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.56 | 119.76B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
551.00 | 59.14B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.70 | 41.40B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
568.78 | 32.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
278.00 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-24 | Eingeleitet | Leerink Partners | Outperform |
| 2024-10-14 | Eingeleitet | Guggenheim | Buy |
| 2024-09-30 | Eingeleitet | William Blair | Outperform |
| 2017-05-18 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | Eingeleitet | MLV & Co | Buy |
| 2014-11-18 | Eingeleitet | WallachBeth | Buy |
Alle ansehen
Tenax Therapeutics Inc Aktie (TENX) Neueste Nachrichten
How Tenax Therapeutics Inc. stock performs during market volatilityWeekly Double Return List - Newser
Why Tenax Therapeutics Inc. stock attracts strong analyst attentionMarket Timing Advice - Newser
What makes Tenax Therapeutics Inc. stock price move sharplyFree High-Accuracy Stock Picks - Newser
How PTC Therapeutics Inc. stock performs during market volatilityDaily Stock Radar - Newser
(TENX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
(TENX) Investment Analysis - news.stocktradersdaily.com
(TENX) On The My Stocks Page - news.stocktradersdaily.com
Tenax Therapeutics Approves Officer Exculpation Amendment - TipRanks
Two Sigma Investments LP Acquires Shares of 13,521 Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
Millennium Management LLC Acquires New Holdings in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
When (TENX) Moves Investors should Listen - news.stocktradersdaily.com
Where are the Opportunities in (TENX) - news.stocktradersdaily.com
Tectonic, Tenax, others aim for shift in heart failure - BioWorld MedTech
Tenax Therapeutics Reports Increased Losses Amid Strategic Investments - TipRanks
Roth Capital Issues Negative Forecast for TENX Earnings - Defense World
William Blair Cuts Earnings Estimates for Tenax Therapeutics - Defense World
Leerink Partnrs Brokers Boost Earnings Estimates for TENX - Defense World
What is William Blair’s Estimate for TENX FY2028 Earnings? - Defense World
Roth Capital Has Bearish Forecast for TENX FY2028 Earnings - Defense World
Tenax Therapeutics (NASDAQ:TENX) Now Covered by StockNews.com - Defense World
Tenax Therapeutics: Q1 Earnings Snapshot - Bluefield Daily Telegraph
Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX S - GuruFocus
Analyst Adjusts Tenax Therapeutics (TENX) Price Target, Maintains Buy Rating | TENX Stock News - GuruFocus
Tenax Therapeutics (TENX) Advances Phase 3 Studies in 2025 | TEN - GuruFocus
Tenax Therapeutics Inc Reports Q1 2025 Net Loss of $10.4 Million Amid Rising R&D and Administrative Expenses - GuruFocus
Tenax Therapeutics (TENX) Projects Funding Through 2027 | TENX Stock News - GuruFocus
Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Tenax Advances Breakthrough PH-HFpEF Treatment: Phase 3 Trial Updates and $111M War Chest Revealed - Stock Titan
Tenax Therapeutics: A High-Reward Play on a $B Market’s First-in-Class Breakthrough - AInvest
Tenax Therapeutics (TENX) Projected to Post Earnings on Tuesday - Defense World
(TENX) Technical Data - news.stocktradersdaily.com
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated by Analysts at StockNews.com - Defense World
Geode Capital Management LLC Boosts Stock Position in Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World
Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at StockNews.com - Defense World
Form SC 13G/AStatement of Beneficial Ownership by Certain Investors: [Amend] - ADVFN
SEC Form DEF 14A filed by Tenax Therapeutics Inc. - Quantisnow
Form DEF 14A TENAX THERAPEUTICS, INC. For: Apr 24 - StreetInsider
Tenax Therapeutics Advances Cardiopulmonary Therapies - TipRanks
Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - The Globe and Mail
Oxygen Biotherapeutics, Inc. : Oxygen Biotherapeutics Announces Third Quarter FY2013 Financial Results Conference Call and Webcast - marketscreener.com
Teanx Therapeutics plans secondary offering - MSN
Tenax: Phase 3 Heart Failure Program Continues With 2 Key Catalysts - Seeking Alpha
Tenax Therapeutics (TENX) Files Prospectus for Stock Resale - GuruFocus
Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.43%
1.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):